Targeting TANK-binding kinase 1 (TBK1) in cancer.

Saved in:
Bibliographic Details
Title: Targeting TANK-binding kinase 1 (TBK1) in cancer.
Authors: Revach OY; Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Medical School , Boston, MA, USA., Liu S; Laboratory of Systems Pharmacology, Harvard Medical School , Boston, MA, USA., Jenkins RW; Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Medical School , Boston, MA, USA.
Source: Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2020 Nov; Vol. 24 (11), pp. 1065-1078. Date of Electronic Publication: 2020 Oct 05.
Publication Type: Journal Article; Review
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101127833 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7631 (Electronic) Linking ISSN: 14728222 NLM ISO Abbreviation: Expert Opin Ther Targets Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-7631
DOI:10.1080/14728222.2020.1826929